Paper25057166
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.
Missiaglia E and 14 others. Ann Oncol, 2014. Cited by 534 papers, by iCite.
Cite this record
ConductScience Library. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Papers, record 25057166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25057166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colonic Neoplasms | Major topic |
| Neoplasm Proteins | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| DNA Copy Number Variations | |
| Disease-Free Survival | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Male | |
| Microsatellite Instability | |
| Neoplasm Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| Proto-Oncogene Mas | |
| Translational Research, Biomedical |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05186116 | LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis | Results |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 32590893 | Corrections to "Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features". | https://conductscience.org/library/papers/32590893 |
Source PubMed
Cited by376
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 534 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42785685 | Merkel Cell Polyomavirus in colorectal cancer: exploring the Wnt/β-catenin pathway. | Virus Res | 2026 | https://conductscience.org/library/papers/42785685 | PubMed |
| 42783081 | Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study. | Clin Pract | 2026 | https://conductscience.org/library/papers/42783081 | PubMed |
| 42776613 | Early-onset colorectal cancer in Sweden: increase in distal tumors but a shift in right-sided incidence, 2020-2024. | JNCI Cancer Spectr | 2026 | https://conductscience.org/library/papers/42776613 | PubMed |
| 42621110 | CPS1 promotes colorectal cancer progression by inducing EMT and activating TGF-β/Smad signaling pathway. | iScience | 2026 | https://conductscience.org/library/papers/42621110 | PubMed |
| 42490794 | Divergent Prognostic Impact of Histopathological Features and Combined Hematological-Biochemical Indices in Rectal Versus Colorectal Cancer: A Single-Center Study. | World J Oncol | 2026 | https://conductscience.org/library/papers/42490794 | PubMed |
| 42426557 | Anti-Human Epidermal Growth Factor Receptor 2 therapies in metastatic colorectal cancer: a systematic review and meta-analysis. | Oncologist | 2026 | https://conductscience.org/library/papers/42426557 | PubMed |
| 42402743 | Architectural patterns of growth of colon adenocarcinoma - comparative study. | Rom J Morphol Embryol | 2026 | https://conductscience.org/library/papers/42402743 | PubMed |
| 42395139 | Differential Prognostic Impact of Prior Cholecystectomy Between Proximal and Distal Colorectal Cancer: A 12-Year Retrospective Cohort Study of 3487 Consecutive Patients. | Ann Gastroenterol Surg | 2026 | https://conductscience.org/library/papers/42395139 | PubMed |
| 42356476 | O-Glycosylation Signatures Shape the Tumour Immune Microenvironment and Associate with Genomic Stability, Drug Resistance Programmes, and Epithelial Differentiation in Colorectal Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356476 | PubMed |
| 42185684 | Gut microbiota profiles in reactive and metastatic lymphadenopathy in colorectal cancer: a tumor location-stratified analysis. | Int J Colorectal Dis | 2026 | https://conductscience.org/library/papers/42185684 | PubMed |
| 42169599 | The Prognostic and Predictive Value of METTL3 in Metastatic Colorectal Cancer. | Asian Pac J Cancer Prev | 2026 | https://conductscience.org/library/papers/42169599 | PubMed |
| 42146810 | Prognostic and Predictive Role of Lymph Node Count in Stage II Colon Cancer: A Retrospective Analysis of a Japanese Nationwide Cohort. | Ann Gastroenterol Surg | 2026 | https://conductscience.org/library/papers/42146810 | PubMed |
| 42104745 | The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in Germany. | Int J Cancer | 2026 | https://conductscience.org/library/papers/42104745 | PubMed |
| 41930293 | Prognostic impact of clinical factors in MSI-H/dMMR gastrointestinal tumors treated with immune checkpoint inhibitors: results from a multicenter real-world study. | ESMO Real World Data Digit Oncol | 2026 | https://conductscience.org/library/papers/41930293 | PubMed |
| 41790744 | Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine. | PLoS One | 2026 | https://conductscience.org/library/papers/41790744 | PubMed |
| 41752880 | Clinicopathological Features of Right vs. Left Colorectal Carcinomas: Do the Differences Really Matter? | Life (Basel) | 2026 | https://conductscience.org/library/papers/41752880 | PubMed |
| 41751211 | Association of Cancer-Associated Venous Thromboembolism with the Primary Site of Colorectal Cancer, with Respect to KRAS/NRAS/BRAF Mutations. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751211 | PubMed |
| 41694495 | Anatomical laterality of primary intestinal diffuse large B-cell lymphoma independently stratifies survival: New prognostic nomogram incorporating tumor location. | World J Gastroenterol | 2026 | https://conductscience.org/library/papers/41694495 | PubMed |
| 41613807 | Evolution or Revolution in Colorectal Cancer Treatment: Present and Future of New Therapeutic Options. A Narrative Review. | Oncol Res | 2026 | https://conductscience.org/library/papers/41613807 | PubMed |
| 41595218 | Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41595218 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25057166
GET https://conductscience.org/api/papers/v1/25057166/cited_by?page=2